Connect-Home: Alzheimer's Disease and Related Dementias

Launched by UNIVERSITY OF NORTH CAROLINA, CHAPEL HILL · Feb 17, 2025

Keywords

ClinConnect Summary

The Connect-Home trial is researching a program designed to help patients with Alzheimer's disease and related dementias, along with their caregivers, during the transition from skilled nursing facilities (SNFs) back to home or other living arrangements. The goal is to ease the stress on caregivers and improve the mental and emotional well-being of patients during this important time. The study is currently recruiting participants aged 65 and older who can speak English and have a diagnosis of dementia. Eligible patients must also have a caregiver who is willing to join in the study.

If you or a loved one participates, you can expect support through the transition process, which may help reduce both caregiver strain and challenging symptoms faced by patients. To qualify, patients should not have any planned hospital visits within 30 days of enrolling in the study, and caregivers need to be actively involved and able to communicate effectively. This trial aims to make a meaningful difference for families navigating the complexities of Alzheimer's care.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• Patients:
• • Ability to speak English
• • Goal of discharge to home, assisted living, or long-term care
• • Diagnosis of dementia
• • Having a caregiver willing to participate
• Caregivers:
• • Ability to speak English
• • Legally authorized representative (LAR) who also provides support for the person with ADRD
• Inclusion criteria for SNFs:
• • Location within 120 miles of UNC-Chapel Hill
• • Admission of at least 75 SNF patients per year
• Exclusion Criteria:
• Patients:
• • Planned hospital readmission for procedures or treatments within 30 days post enrollment.
• Caregivers:
• • LAR is a court-appointed guardian.